Prostate PET/CT targets more cancer and improves patient care

(Society of Nuclear Medicine) A new study that includes data from four Australian medical centers shows that Ga-68 Prostate Specific Membrane Antigen (PSMA) PET/CT detects prostate cancer not caught by more conventional imaging, thus affecting treatment plans. The research was presented at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news